Protein Production Platform: The Digest’s 2021 Multi-Slide Guide to Dyadic

Now that all Americans 16 years and older are eligible for Covid-19 vaccines as of yesterday, the timing is perfect for this Dyadic presentation that dives into their proprietary & patented C1-cell chromosomal gene expression and recombinant protein production platform to which can produce large quantities of vaccines, antibodies, enzymes and other protein-based products.